BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 18329998)

  • 1. Clinical pharmacology of parenteral use of antiepileptic drugs.
    Bialer M
    Epilepsia; 2007; 48 Suppl 8():46-8. PubMed ID: 18329998
    [No Abstract]   [Full Text] [Related]  

  • 2. A new antiepileptic drug.
    Shorvon SD; van Rijckevorsel K
    J Neurol Neurosurg Psychiatry; 2002 Apr; 72(4):426-9. PubMed ID: 11909894
    [No Abstract]   [Full Text] [Related]  

  • 3. Resting-state fMRI revealed different brain activities responding to valproic acid and levetiracetam in benign epilepsy with central-temporal spikes.
    Zhang Q; Yang F; Hu Z; Zhang Z; Xu Q; Dante M; Wu H; Li Z; Li Q; Li K; Lu G
    Eur Radiol; 2017 May; 27(5):2137-2145. PubMed ID: 27553940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct and indirect comparison meta-analysis of levetiracetam versus phenytoin or valproate for convulsive status epilepticus.
    Brigo F; Bragazzi N; Nardone R; Trinka E
    Epilepsy Behav; 2016 Nov; 64(Pt A):110-115. PubMed ID: 27736657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of four antiepileptic drugs in status epilepticus: experience from India.
    Misra UK; Kalita J
    Int J Neurosci; 2016 Nov; 126(11):1013-9. PubMed ID: 26456955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absence of pharmacokinetic drug interaction of levetiracetam with phenytoin in patients with epilepsy determined by new technique.
    Browne TR; Szabo GK; Leppik IE; Josephs E; Paz J; Baltes E; Jensen CM
    J Clin Pharmacol; 2000 Jun; 40(6):590-5. PubMed ID: 10868309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concerns with antiepileptic drug initiation: safety, tolerability, and efficacy.
    Ferrendelli JA
    Epilepsia; 2001; 42 Suppl 4():28-30. PubMed ID: 11564122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacology and clinical results of levetiracetam (E Keppra(®) Tablets), a new antiepileptic drug].
    Ishii Y; Tanaka T
    Nihon Yakurigaku Zasshi; 2011 Feb; 137(2):95-102. PubMed ID: 21321459
    [No Abstract]   [Full Text] [Related]  

  • 9. The 'number needed to treat' with Levetiracetam (LEV): comparison with the other new antiepileptic drugs (AEDs).
    van Rijckevorsel K; Boon PA
    Seizure; 2001 Apr; 10(3):235-6. PubMed ID: 11437625
    [No Abstract]   [Full Text] [Related]  

  • 10. Synergistic effects of oxiracetam and piracetam in combination with antiepileptic drugs.
    Mondadori C; Schmutz M
    Acta Neurol Scand Suppl; 1986; 109():113-6. PubMed ID: 3096070
    [No Abstract]   [Full Text] [Related]  

  • 11. Developmental and therapeutic pharmacology of antiepileptic drugs.
    Miura H
    Jpn J Psychiatry Neurol; 1993 Jun; 47(2):169-74. PubMed ID: 8271538
    [No Abstract]   [Full Text] [Related]  

  • 12. Levetiracetam, a new antiepileptic agent: lack of in vitro and in vivo pharmacokinetic interaction with valproic acid.
    Coupez R; Nicolas JM; Browne TR
    Epilepsia; 2003 Feb; 44(2):171-8. PubMed ID: 12558570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid infusion of a loading dose of intravenous levetiracetam with minimal dilution: a safety study.
    Wheless JW; Clarke D; Hovinga CA; Ellis M; Durmeier M; McGregor A; Perkins F
    J Child Neurol; 2009 Aug; 24(8):946-51. PubMed ID: 19264738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of co-medications on lamotrigine clearance in Japanese children with epilepsy.
    Takeuchi T; Natsume J; Kidokoro H; Ishihara N; Yamamoto H; Azuma Y; Ito Y; Kurahashi N; Tsuji T; Suzuki M; Itomi K; Yamada K; Kurahashi H; Abe S; Okumura A; Maruyama K; Negoro T; Watanabe K; Kojima S
    Brain Dev; 2016 Sep; 38(8):723-30. PubMed ID: 27033151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of Levetiracetam in Prophylaxis of Early Post-Traumatic Seizures.
    Javed G; Waqas M; Qadeer M; Bari E; Murtaza G
    Turk Neurosurg; 2016; 26(5):732-5. PubMed ID: 27337228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of body composition in persons with epilepsy on conventional & new antiepileptic drugs.
    Sarangi SC; Tripathi M; Kakkar AK; Gupta YK
    Indian J Med Res; 2016 Mar; 143(3):323-30. PubMed ID: 27241646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Region-specific changes in gene expression in rat brain after chronic treatment with levetiracetam or phenytoin.
    Hassel B; Taubøll E; Shaw R; Gjerstad L; Dingledine R
    Epilepsia; 2010 Sep; 51(9):1714-20. PubMed ID: 20345932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levetiracetam attenuates spontaneous spike-and-wave discharges in DBA/2J mice.
    Marrosu F; Bortolato M; Frau R; Orrù M; Puligheddu M; Fà M; Muroni A; Tuveri A; Mereu G
    Epilepsy Res; 2007 Jul; 75(2-3):224-7. PubMed ID: 17624733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dexamethasone alone and in combination with desipramine, phenytoin, valproic acid or levetiracetam interferes with 5-ALA-mediated PpIX production and cellular retention in glioblastoma cells.
    Lawrence JE; Steele CJ; Rovin RA; Belton RJ; Winn RJ
    J Neurooncol; 2016 Mar; 127(1):15-21. PubMed ID: 26643803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of levetiracetam on psychosocial and behavioral functioning in children: A case-control and follow-up study.
    Bektaş G; Tekin U; Özkan MU; Yıldız EP; Çalışkan M; Özmen M; Aydınlı N
    Epilepsy Behav; 2017 Jul; 72():39-42. PubMed ID: 28575765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.